EDGAR Filing Documents for 0001558370-24-007646

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001558370-24-007646

Filing Date

2024-05-09

Accepted

2024-05-09 17:10:44

Documents

Period of Report

2024-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	iova-20240331x10q.htm iXBRL	10-Q	2084888
2	EX-10.1	iova-20240331xex10d1.htm	EX-10.1	130791
3	EX-10.2	iova-20240331xex10d2.htm	EX-10.2	156714
4	EX-31.1	iova-20240331xex31d1.htm	EX-31.1	12335
5	EX-31.2	iova-20240331xex31d2.htm	EX-31.2	12222
6	EX-32.1	iova-20240331xex32d1.htm	EX-32.1	7098
7	EX-32.2	iova-20240331xex32d2.htm	EX-32.2	7163
	Complete submission text file	0001558370-24-007646.txt		8921995

Data Files

Seq	Description	Document	Type	Size
8	EX-101.SCH	iova-20240331.xsd	EX-101.SCH	59354
9	EX-101.CAL	iova-20240331_cal.xml	EX-101.CAL	55607
10	EX-101.DEF	iova-20240331_def.xml	EX-101.DEF	265254
11	EX-101.LAB	iova-20240331_lab.xml	EX-101.LAB	453633
12	EX-101.PRE	iova-20240331_pre.xml	EX-101.PRE	403142
87	EXTRACTED XBRL INSTANCE DOCUMENT	iova-20240331x10q_htm.xml	XML	1382460

Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070

Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120

IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)